Tempest Therapeutics Inc Sustainability Reports
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company developing a portfolio of small molecule product candidates with tumor-targeted or immune-mediated mechanisms to treat cancer.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900QLMOA3D8VSCN33
1 reports from 2022 to 2022
Company Profile
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company developing a portfolio of small molecule product candidates with tumor-targeted or immune-mediated mechanisms to treat cancer.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years